Feng-Jing Chen,Juan Francisco Gel,Maria Fernanda Villagra
申请号：
BRPI0921070
公开号：
BRPI0921070A2
申请日:
2009.11.18
申请国别(地区):
BR
年份:
2019
代理人:
摘要：
A pharmaceutical composition of the following Compound (1), a potent hepatitis C viral (HCV) inhibitor, or a pharmaceutically acceptable salt thereof, for oral administration.
